Researchers affiliated with CRID showed that a protein called gasdermin D is involved in septic patients’ organ lesions. The study also proved that a drug originally indicated to treat alcohol dependence can inhibit the molecule’s action and prevent complications.
In a study conducted at the Obesity and Comorbidities Research Center, a bile acid derivative known by the acronym TUDCA reduced food intake and increased energy expenditure in mice, improving quality of life. The results are promising for humans.
Experiments conducted at HUG-CELL showed that besides directly combating tumor cells, zika alerted the immune system to the presence of cancer. The study opens up prospects for the use of virotherapy for central nervous system tumors.
Many patients suffer from a significant decline in immunity lasting for years after they are discharged from hospital. In an article published in the journal Immunity, researchers at CRID reveal why this happens.
The hypothesis was raised by scientists at HUG-CELL, on the basis of an epidemiological survey involving 1,744 Brazilian couples where at least one partner was infected.
In a study of the underlying mathematical pattern associated with the reign of the Caesars, researchers at CeMEAI concluded that the chances of survival obeyed the 80/20 rule seen in many phenomena, from earthquake magnitudes to numbers of followers on social media.
Scientists at CIBFar investigated the mechanism that produces the main enzyme involved in the virus’s replication in cells. The findings are reported in the Journal of Molecular Biology
Designed and built by researchers at the Center for Development of Functional Materials, the device is much cheaper than the conventional technology.
Brazilian scientists have developed an innovation that can be used in sensors to monitor brain function with even greater sensitivity than existing devices.
R. Pio XI, 1500 - Alto da Lapa - CEP 05468-901 São Paulo/SP - Brasil